组织型转谷氨酰胺酶抗体在自身免疫性甲状腺疾病患者乳糜泻筛查中的应用及临床特征分析
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
目的探究自身免疫性甲状腺疾病(autoimmune thyroid disease,AITD)患者乳糜泻(celiac disease,CD)特异性自身抗体组织型转谷氨酰胺酶抗体(tissue transglutaminase antibody,tTGA)的阳性率及CD相关临床症状的发生率。方法研究纳入南京医科大学附属逸夫医院内分泌科门诊就诊或住院的AITD患者208例,同时招募120名健康人为对照组。采用放射配体法检测所有研究对象血清CD特异性自身抗体tTGA的水平,填写CD临床症状筛查表。AITD患者分别根据甲状腺疾病类型和是否合并1型糖尿病(type 1 diabetes mellitus,T1DM)进行分组,比较各组tTGA阳性率情况。此外,根据tTGA是否阳性将AITD患者分为tTGA+组和tTGA-组,评价CD相关临床症状与tTGA的相关性。结果AITD患者按照甲状腺疾病类型分组,格雷夫斯病(Graves’ disease,GD)组患者和桥本甲状腺炎(hashimoto’s thyroiditis,HT)组患者tTGA阳性率均显著高于健康对照组(均P
Fields of Study & Subjects
Celiac Disease Research and Management
Autoimmune Neurological Disorders and Treatments
Inflammatory Bowel Disease
Publication details
- Journal / source
- DOAJ (DOAJ: Directory of Open Access Journals)
- Publication date
- 1 March 2026
- Language
- ZH